At Fe Pharmaceuticals, we develop innovative iron binding polymers to treat serious diseases. Committed to excellence and innovation, we aim to improve health outcomes and enhance quality of life for patients.
Iron is an irreplaceable requirement for almost all living organisms.
Iron is crucial to the functioning of life-essential enzymes involved in energy production, deoxyribonucleic acid (DNA) synthesis and cellular defense systems.
Paradoxically, excess amounts of iron can be toxic because it catalyzes production of free radicals which damage cells and tissues.
Our bodies balance needs for iron and its toxicity through tightly controlled iron homeostatic mechanisms, but dysregulation of these can lead to a wide variety of diseases including infection, cancer, and inflammatory diseases.
Our mission is to treat serious and life-threatening diseases where iron is involved in disease pathogenesis.
Fe Pharmaceuticals is developing purpose-designed, non-toxic, iron binding polymers to manage iron and thereby manage disease.
Our first drug candidate is effective in experimental models against diseases involving cell proliferation: infectious diseases and cancer.